Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Item

Notes

Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business)

Currently we have 19 named members, so 2/3 = 12 (excluding chair and government members).

 

Open Meeting

HIMSS Proposal

  • Eric and Julia

  • Review

  • Vote to approve submission

  • Submissions Due June 10th

Follow up Items -

  • Special Topic calls:

    • Next dates:

      • June 11th - CWRDi Dr. James Crawford

      • July 9th - Open, Specimen CrossMapping Table?

      • August

    • Proposed:

      • Use of standards and reporting across the different systems used in Cancer and Pathology - ask CAP folks if interested / someone available (Scott offered)

  • Follow up from Collaborative Community Report to FDA - Keith / Vickie

Review Working Groups progress

Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid

ONC Feedback

Roadmap section updates in response to ONC comments on the SHIELD roadmap - NOT DISCUSSED

  1. The roadmap mission section describes a broad vision of lab interoperability. However, the roadmap proposed solution is limited to the FDA use cases around In-vitro diagnostics (IVD) data, specifically populating the IVD data hub.  ONC suggests clearly describing the roadmap scope so the proposed solutions can be discussed within that context.

From last SC call: Nick will connect with Sara to get more context and then bring this to the IVD datahub group - then Nick will bring back here (smile)

  1. The roadmap identifies training and education needs around using LOINC as a barrier to interoperability. ONC suggests clarifying how the roadmap addresses this barrier. ONC recognizes that terminologies require training and education, and replacing LOINC with another standard will not address the barrier.

Update from Standards and Vocab WG about re-write of this section?

  1. There are several solutions proposed, including repositories and tools, which need to be further evaluated before ONC could fully support the roadmap.  ONC suggests the roadmap be updated to include details around feasibility, scalability and how the proposed changes can be integrated into the current laboratory ecosystem (e.g., regulation and industry).

Identify components that could improve the ecosystem infrastructure, and then highlight the places where these components can be advanced / sustained or made easier to implement. Would SHIELD be willing to consider to provide an exampel implementation - create the structures and bound terminologies to showcase how each element would be properly represented be working.

Looking for volunteer to tackle this re-write: For each of the Consideration sections we could certainly add a section on feasibility / requirements (e.g. continued funding for LIDR, better describing the intended use of ANY data element added, overall goal of LIDR, clearly delineate what is commonly used and is minimum, provide best practice and alternatives (non-preferred) - example would be metadata around the value sets in VSAC (curation / usage etc) to be able to ascertain quality) and highlight that other mechanisms are needed to achieve for adoption.

Antimicrobial result reporting - NOT DISCUSSED

Placeholder to get back to later

Related work at HL7 Europe:

View file
nameEU coded value sets.xlsx

Next calls - NOT DISCUSSED

All SHIELD:

General Updates: June 25, 2024

Ask about SC: June 18, 2024

July 4th week call availability

Adjourned

: PM ET

...